Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects

by Raisa Kraaijvanger, Montse Janssen Bonás, Adriane D. M. Vorselaars, Marcel Veltkamp, Marcel Veltkamp
Published 2020-07-01

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

by Milou C. Schimmelpennink, Adriane D. M. Vorselaars, Marcel Veltkamp, Ruth G. M. Keijsers
Published 2019-06-01

Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy

by Adriane D. M. Vorselaars, Elisabeth V. Sjögren, Coline H. M. van Moorsel, Jan C. Grutters
Published 2013-01-01

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease

by Sofia A. Moll, Mark G.J.P. Platenburg, Anouk C.M. Platteel, Adriane D.M. Vorselaars, Montse Janssen Bonàs, Claudia Roodenburg-Benschop, Bob Meek, Coline H.M. van Moorsel, Jan C. Grutters
Published 2020-09-01